Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Endo Pharmaceuticals Inc. et al v. Watson Laboratories Inc.
Case Number:
1:10-cv-00138
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 29, 2012
Watson, Endo Settle Generic Lidoderm Patent Suit
Watson Pharmaceuticals Inc. and Endo Pharmaceuticals Inc. have settled all of their outstanding patent litigation related to Watson's generic version of the brand-name lidocaine patch Lidoderm, the drugmakers said Tuesday.
-
June 28, 2011
Judge Agrees With Watson's Take On Lidoderm Patent
A Delaware federal judge on Monday dealt a blow to Endo Pharmaceuticals Inc. in its patent fight with Watson Laboratories Inc. over topical pain-relief patch technology, agreeing with the generic-drug maker's interpretation of the patent's language.